| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5942378 | Annals of Vascular Surgery | 2014 | 7 Pages |
Abstract
Our case series is the first that describes CDT/UCDT as an effective and safe therapy for pediatric patients with severe PE. CDT is known to accelerate fibrinolysis via focused delivery of thrombolytic agent to the thrombus site. For carefully selected patients, CDT/UCDT provides a useful treatment option for severe PE irrespective of the etiology, predisposing conditions, and associated comorbidities.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Aarti C. Bavare, Swati X. Naik, Peter H. Lin, Mun Jye Poi, Donald L. Yee, Ronald A. Bronicki, Joseph X. Philip, Moreshwar S. Desai,